GLOBAL NEWBORN SCREENING MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

GLOBAL NEWBORN SCREENING MARKET 2019-2027

Market By Product, Test Type, Technology And Geography | Forecast 2019-2027

Request Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research has arrived upon the conclusion that the global market for newborn screening is estimated to snowball with a CAGR of 13.76% in the forecasting period of 2019 to 2027.

Newborn screening is the process of screening infants shortly after birth. The conditions vary from treatable diseases to irreversible conditions. Metabolites and enzyme activity from the blood samples are measured by the majority of the newborn screens. Congenital heart defects using pulse oximetry and automated auditory brainstem response are used to determine heart diseases and hearing loss, respectively. If the screening shows positive results, then further testing is done to confirm the disease. 

The newborn screening market report from Triton gives a detailed analysis of the market definition, key insights, evolution & transition of newborn screening, Porter’s five force analysis, key impact analysis, market attractiveness index, vendor scorecard, industry components, regulatory framework, industry player positioning and the key market strategies that have been studied for the newborn screening market. 

The global newborn screening market is primarily driven by the rising prevalence of diseases among newborns. The newborns suffer from various diseases that include hearing disorders, congenital disorders, neonatal infection, respiratory distress syndrome and others. Newborn screening is performed to seek evidence of certain genetic and endocrine diseases. The screening helps to identify a list of medical conditions, including sickle cell disease (SS, SC, etc.), congenital hypothyroidism (CH), galactosemia (GAL), phenylketonuria, etc.

Key opportunities such as the increasing fertility rates across the globe are creating dynamic growth. Newborn screening helps in the early identification and management of affected newborns, technological advancements in newborn screening and an increase in the number of pregnant women with advanced maternal age are pushing the market growth over the projected period.

The dearth of skilled professionals in the healthcare industry and the maintenance of equipment in hospitals are the key challenges that are curbing the growth of the market globally.

Geographically, the global newborn screening equipment market covers five major regions, which are:

•    North America: United States and Canada

•    Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia-Pacific

•    Europe: United Kingdom, Germany, France, Spain, Italy, Russia and Rest of Europe

•    Latin America: Brazil, Mexico and Rest of Latin America

•    The Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of the Middle East & Africa

Global newborn screening market segmentation:

The global newborn screening market segmented on the basis of product, test type and technology:

•    By Product has been sub-segmented into: 

O    Newborn screening instruments

O    Newborn screening reagents & assay kits

•    By Test type has been sub-segmented into:

O    Hearing screen test

O    Critical congenital heart disease (CCHD) Test

O    Dry blood spot test

•    By Technology has been sub-segmented into:

O    Tandem Mass Spectrometry

O    Pulse Oximetry

O    Enzyme-based assays

O    DNA-based assays

O    Electrophoresis

O    Others

The top companies that have been studied in the market are Medtronic Plc, PerkinElmer, Inc., Waters Corporation, Thermo Fisher Scientific, Inc., NeoGen Labs Pvt. Ltd., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Natus Medical, Incorporated, Trivitron Healthcare, GE Healthcare, Limited, Masimo Corporation, ZenTech S.A., Cardinal Health, Inc., SCIEX and BioTek Instruments, Inc.

The strategic analysis for each of these companies in the newborn screening market has been covered in detail. The company market share helps in diving into the information about the key market players and the hold of each company on the market.


Related Reports

ASIA PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2019-2027
Lifesciences

ASIA PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2019-2027

Market By Offerings, Technolog ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027
Lifesciences

ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027

Market By Therapeutics & Diagn ..

VIEW REPORT
ASIA-PACIFIC BIOSURGERY MARKET 2019-2027
Lifesciences

ASIA-PACIFIC BIOSURGERY MARKET 2019-2027

Market By Product, Application ..

VIEW REPORT
ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027
Lifesciences

ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027

Market By Blood Type, Applicat ..

VIEW REPORT
ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027

Market By Test Types, Technolo ..

VIEW REPORT
ASIA-PACIFIC CLEANROOM TECHNOLOGY MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CLEANROOM TECHNOLOGY MARKET 2019-2027

Market By Component, End-user ..

VIEW REPORT
ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027

Market By Age Group, Education ..

VIEW REPORT

Table of Content

1. GLOBAL NEWBORN SCREENING MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.2.1. SUPPORTIVE GOVERNMENT POLICIES IN US AND CANADA

2.2.2. DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY

2.2.3. GROWTH IN DRY BLOOD SPOT TEST

2.2.4. TECHNIQUES USED IN NEWBORN SCREENING TESTS

2.3. EVOLUTION & TRANSITION OF NEWBORN SCREENING

2.4. PORTER’S FIVE FORCE ANALYSIS

2.4.1. THREAT OF NEW ENTRANTS

2.4.2. THREAT OF SUBSTITUTE

2.4.3. BARGAINING POWER OF SUPPLIERS

2.4.4. BARGAINING POWER OF BUYERS

2.4.5. THREAT OF COMPETITIVE RIVALRY

2.5. KEY IMPACT ANALYSIS

2.5.1. RELIABILITY

2.5.2. COST

2.5.3. AVAILABILITY

2.5.4. TECHNOLOGICAL ADVANCEMENT

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. INDUSTRY COMPONENTS

2.8.1. RAW MATERIAL SUPPLIERS

2.8.2. MANUFACTURERS

2.8.3. DISTRIBUTORS

2.8.4. END-USERS

2.9. REGULATORY FRAMEWORK

2.10. INDUSTRY PLAYER POSITIONING

2.11. KEY MARKET STRATEGIES

2.11.1. PRODUCT LAUNCH

2.12. MARKET DRIVERS

2.12.1. INCREASE IN OCCURRENCES OF NEWBORN DISEASES

2.12.2. GROWING NUMBER OF INFANTS WITH BIRTH DEFECT

2.12.3. BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH

2.12.4. RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE

2.13. MARKET RESTRAINTS

2.13.1. ABSENCE OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES

2.13.2. SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING

2.14. MARKET OPPORTUNITIES

2.14.1. INCREASING FERTILITY RATES ACROSS THE GLOBE IS CREATING DYNAMIC GROWTH

2.14.2. NEWBORN SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS

2.14.3. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING

2.14.4. INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE

2.15. MARKET CHALLENGES

2.15.1. DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY

2.15.2. MAINTENANCE OF EQUIPMENT IN HOSPITAL

3. NEWBORN SCREENING MARKET OUTLOOK - BY PRODUCT

3.1. NEWBORN SCREENING INSTRUMENTS

3.2. NEWBORN SCREENING REAGENTS & ASSAY KITS

4. NEWBORN SCREENING MARKET OUTLOOK - BY TEST TYPE

4.1. HEARING SCREEN TEST

4.2. CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST

4.3. DRY BLOOD SPOT TEST

5. NEWBORN SCREENING MARKET OUTLOOK - BY TECHNOLOGY

5.1. TANDEM MASS SPECTROMETRY

5.2. PULSE OXIMETRY

5.3. ENZYME-BASED ASSAYS

5.4. DNA-BASED ASSAYS

5.5. ELECTROPHORESIS

5.6. OTHERS

6. NEWBORN SCREENING MARKET - REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1. MARKET BY PRODUCT

6.1.2. MARKET BY TEST TYPE

6.1.3. MARKET BY TECHNOLOGY

6.1.4. COUNTRY ANALYSIS

6.1.4.1. UNITED STATES

6.1.4.2. CANADA

6.2. EUROPE

6.2.1. MARKET BY PRODUCT

6.2.2. MARKET BY TEST TYPE

6.2.3. MARKET BY TECHNOLOGY

6.2.4. COUNTRY ANALYSIS

6.2.4.1. UNITED KINGDOM

6.2.4.2. GERMANY

6.2.4.3. FRANCE

6.2.4.4. SPAIN

6.2.4.5. ITALY

6.2.4.6. RUSSIA

6.2.4.7. REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1. MARKET BY PRODUCT

6.3.2. MARKET BY TEST TYPE

6.3.3. MARKET BY TECHNOLOGY

6.3.4. COUNTRY ANALYSIS

6.3.4.1. CHINA

6.3.4.2. JAPAN

6.3.4.3. INDIA

6.3.4.4. SOUTH KOREA

6.3.4.5. ASEAN COUNTRIES

6.3.4.6. AUSTRALIA & NEW ZEALAND

6.3.4.7. REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1. MARKET BY PRODUCT

6.4.2. MARKET BY TEST TYPE

6.4.3. MARKET BY TECHNOLOGY

6.4.4. COUNTRY ANALYSIS

6.4.4.1. BRAZIL

6.4.4.2. MEXICO

6.4.4.3. REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1. MARKET BY PRODUCT

6.5.2. MARKET BY TEST TYPE

6.5.3. MARKET BY TECHNOLOGY

6.5.4. COUNTRY ANALYSIS

6.5.4.1. UNITED ARAB EMIRATES

6.5.4.2. TURKEY

6.5.4.3. SAUDI ARABIA

6.5.4.4. SOUTH AFRICA

6.5.4.5. REST OF MIDDLE EAST & AFRICA

7. COMPETITIVE LANDSCAPE

7.1. SCIEX

7.2. BIOTEK INSTRUMENTS, INC.

7.3. BIO-RAD LABORATORIES, INC.

7.4. CARDINAL HEALTH, INC.

7.5. GE HEALTHCARE, LIMITED

7.6. AGILENT TECHNOLOGIES, INC.

7.7. MASIMO CORPORATION

7.8. NATUS MEDICAL, INCORPORATED

7.9. MEDTRONIC PLC

7.10. THERMO FISHER SCIENTIFIC, INC.

7.11. NEOGEN LABS PVT. LTD.

7.12. PERKINELMER, INC.

7.13. ZENTECH S.A.

7.14. WATERS CORPORATION

7.15. TRIVITRON HEALTHCARE

8. METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1: GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS INDEX

TABLE 3: VENDOR SCORECARD

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: LIST OF PRODUCT LAUNCHES

TABLE 6: GLOBAL INCIDENCE OF CHROMOSOMAL ABNORMALITIES IN NEWBORNS

TABLE 7: LEADING CAUSE OF INFANT DEATHS IN THE UNITED STATES

TABLE 8: INFANT MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATHS/ 1000 LIVE BIRTHS)

TABLE 9: GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)

TABLE 10: GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)

TABLE 11: GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)

TABLE 12: GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)

TABLE 13: NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 14: NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)

TABLE 15: NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)

TABLE 16: NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)

TABLE 17: EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 18: EUROPE NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)

TABLE 19: EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)

TABLE 20: EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)

TABLE 21: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 22: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)

TABLE 23: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)

TABLE 24: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)

TABLE 25: LATIN AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 26: LATIN AMERICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)

TABLE 27: LATIN AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)

TABLE 28: LATIN AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)

TABLE 29: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 30: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)

TABLE 31: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)

TABLE 32: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: KEY BUYING IMPACT ANALYSIS

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: INDUSTRY PLAYER POSITIONING IN 2018 (IN %)

FIGURE 5: CAUSES OF DEATH AMONG NEWBORNS WORLDWIDE (0-27 DAYS)

FIGURE 6: FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) IN 2017

FIGURE 7: GLOBAL NEWBORN SCREENING MARKET, BY NEWBORN SCREENING INSTRUMENTS, 2019-2027 (IN $ MILLION)

FIGURE 8: GLOBAL NEWBORN SCREENING MARKET, BY NEWBORN SCREENING REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)

FIGURE 9: GLOBAL NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)

FIGURE 10: GLOBAL NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)

FIGURE 11: GLOBAL NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)

FIGURE 12: GLOBAL NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $ MILLION)

FIGURE 13: GLOBAL NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)

FIGURE 14: GLOBAL NEWBORN SCREENING MARKET, BY ENZYME-BASED ASSAY, 2019-2027 (IN $ MILLION)

FIGURE 15: GLOBAL NEWBORN SCREENING MARKET, BY DNA-BASED ASSAYS, 2019-2027 (IN $ MILLION)

FIGURE 16: GLOBAL NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)

FIGURE 17: GLOBAL NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)

FIGURE 18: GLOBAL NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

FIGURE 19: UNITED STATES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 20: CANADA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 21: UNITED KINGDOM NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 22: GERMANY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 23: FRANCE NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 24: SPAIN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 25: ITALY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 26: RUSSIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 27: REST OF EUROPE NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 28: CHINA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 29: JAPAN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 30: INDIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 31: SOUTH KOREA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 32: ASEAN COUNTRIES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 33: AUSTRALIA & NEW ZEALAND NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 34: REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 35: BRAZIL NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 36: MEXICO NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 37: REST OF LATIN AMERICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 38: UNITED ARAB EMIRATES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 39: TURKEY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 40: SAUDI ARABIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 41: SOUTH AFRICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 42: REST OF MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;